Bio Solution Co., Ltd. develops, manufactures, and sells cell therapy products globally. Its offerings include CartiLife for articular cartilage defects, KeraHeal-Allo for deep second-degree burn wounds, and KeraHeal for skin wounds. The company also provides reconstructed human micro-tissue models such as KeraSkin, SoluAirway, and SoluLiver, along with human-derived primary cell cultures and cosmetics raw materials. Formerly MCTT Bio Co., Ltd., it changed its name to Bio Solution Co., Ltd. in January 2016, was founded in 2000, and is headquartered in Seoul, South Korea.